INVESTOR RELATIONS: Transparency and Up-to-Date Information
Direct and current finance information is the basis for trustworthy communication with stockholders, investors and analysts.
We provide comprehensive information about the NEXUS-Group from the viewpoint of the financial market as well as about NEXUS stocks on the following pages. You can also view our financial reports online and establish contact with our IR team.
NEXUS AG's business model focuses on supporting medical facilities in the organization and treatment of patients using software solutions. The associated responsibility for the processes and treatment success in healthcare facilities is a key part of our business success. This means that social and sustainable work is particularly important for our business model. For this reason, we strive to act responsibly and sustainably in all processes. In addition to economic issues, we also use the ESG (Environmental, Social and Corporate Governance) criteria to measure and control our performance. The development of controlling measures to gauge the achievement of objectives is an essential focus of our activities. To collect and process expectations, ideas and topics relating to sustainable management, we are in regular contact with the stakeholders of our company – in particular employees, shareholders and customers. This exchange also determines where we are going to adjust our strategies. The sustainability documentation is reflected in further or derived documentation.
NEXUS AG's Sustainability Report presents our performance for fiscal year 2019 from a social, environmental and corporate governance perspective and can be viewed on the NEXUS website. Our consolidated financial statements are prepared in accordance with IFRS. The effectiveness of the internal control system for financial reporting has been confirmed by our management. We prepare our non-financial report in accordance with Section 289b and Section 315b of the German Commercial Code (HGB). According to them, we are then obliged to report on social, environmental and other non-financial aspects.
The (Group) Corporate Governance statement (Sections 289a and 315d of the German Commercial Code (HGB) contains the Corporate Governance Statement, information about management practices and the description of the mode of working of the Executive Board and the Supervisory Board. The Corporate Governance Report of NEXUS AG is written jointly by the Executive Board and the Supervisory Board pursuant to Clause 3.10 of the German Corporate Governance Code. It describes the principles of the management and control structures as well as the essential rights of stockholders of NEXUS AG. We pursue the goal of maintaining the description of Corporate Governance clear and succinct. The structures of company management and monitoring of NEXUS AG are as follows:
The Executive Board and Supervisory Board hereby declare that NEXUS AG has complied with the recommendations of the government commission of the German Corporate Governance Code in version of 7 February 2017 – with the following exceptions – and will comply in the future as shown in the compliance statement.
Our image in public is shaped by the appearance, actions and behavior of each individual. We are all responsible for ensuring that NEXUS as a company fulfills its social responsibility. Ethical and legally sound standards are guidelines for our dealings.
With an increase in sales of 14.6 % and an improvement in EBIT of 14.0 %, we were able to show again in 2018 that we can grow dynamically and at the same time improve our results further. This is important to us: We want to continue to pursue the goals of growth and earnings improvement in parallel. Our customers also want us to combine innovation with a serious corporate development.
Dr. Ingo Behrendt
NEXUS STOCKS: Healthcare IT in the Prime Standard
The NEXUS stock is listed on the Frankfurt Stock Exchange.
WKN 522 090 ISIN: DE0005220909 First listing: 24. Juli 2000 Market segment: Prime Standard of the Frankfurt Stock Exchange
The current stock rate tendencies of the NEXUS Group
Nexus Equity, ISIN DE0005220909, WKN 522090
Stock Buyback: Overview
With the ad-hoc announcements of 25 October 2016 and 19 December 2011, the Executive Board of NEXUS AG published the resolution to make use of the empowerment of the respective general stockholders' meeting to purchase own shares of the company in line with Section 71 para. 1 no. 8 of the German Stock Corporation Law (AktG).
The empowerment is restricted to the time period until 30 April 2020 and a scope of 10% of the equity capital. All transactions will be announced monthly at this website monthly after they have been effected.
Responsible company management based on long-term creation of value plays an important role at NEXUS.
Corporate Governance is not a rigid system in our company, but instead a continual process in which value and principles are developed further in line with current requirements.
The NEXUS Group thanks you for visiting this website and for your interest in the products.
These Internet pages and the news published therein constitute neither an offer to sell nor an invitation to buy securities, nor an invitation to submit such an offer. These Internet pages and the information contained therein may only be distributed or otherwise used in accordance with the applicable (securities) regulations. Specifically, distribution in the United States of America (USA), Japan or Canada or to persons (including legal persons) subject to the relevant (securities) restrictions of such countries and to publications with a general distribution in those countries is prohibited.
IR MAILING LIST: We would be happy to send you information directly
You can subscribe to financial reports of NEXUS AG here. As a result, you will receive business and quarterly reports promptly by email.
Separate Non-Financial (Group) Report of NEXUS Group and NEXUS AG
NEXUS AG‘s business model focuses on supporting medical facilities in the organization and treatment of patients using software solutions. The associated responsibility for the
processes and treatment success in healthcare facilities is a key part of our business success. This means that social and sustainable work is particularly important for our business model.
For this reason, we strive to act responsibly and sustainably in all processes. In addition to economic issues, environmental, social and cultural factors have a direct impact on our success. The development of controlling key figures to measure the achievement of targets will become a focal point in future periods.
To collect and process expectations, ideas and topics relating to sustainable management, we are in regular contact with the stakeholders of our company – in particular employees, shareholders and customers. This exchange also determines where we are going to adjust our strategies.